Howard J. Weisman - 13 Apr 2023 Form 4 Insider Report for PaxMedica, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
13 Apr 2023
Net transactions value
$0
Form type
4
Filing time
14 Apr 2023, 19:12:57 UTC
Previous filing
09 Mar 2023
Next filing
28 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PXMD Common Stock Award $0 +180,000 +33% $0.000000 721,633 13 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 180,000 restricted stock units ("RSUs"). The RSUs are subject to time-based vesting with one-third of the RSUs vesting on February 1, 2024, followed by 8.3325% of the remaining RSUs vesting on a quarterly basis thereafter, subject to the reporting person's continuous employment with the Company as of such vesting dates.